Login / Signup

Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials.

Adriaan D de JonghLeonard H van den BergRuben P A van Eijk
Published in: Journal of neurology, neurosurgery, and psychiatry (2020)
Keyphrases
  • amyotrophic lateral sclerosis
  • clinical trial
  • phase ii
  • open label
  • psychometric properties
  • phase iii
  • randomized controlled trial